← Back to Search

Mobile App Monitoring for Recurrent Head and Neck Cancer (QUADSHOT Trial)

N/A

Recruiting

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 75 days

Awards & highlights

QUADSHOT Trial Summary

This trial looks at using a mobile app to monitor health, with the aim of improving patient care.

Who is the study for?

This trial is for adults over 18 with a confirmed diagnosis of head and neck cancer that has come back or spread and can't be treated to cure it. At least six months must have passed since any previous radiotherapy. Participants need to be able to perform daily activities (with an ECOG status of 0-2) and agree to share their smoking history.Check my eligibility

What is being tested?

The study is testing the use of a mobile health platform for real-time assessment and symptom tracking in patients undergoing radiotherapy for recurrent head and neck cancer. It aims to understand how this technology impacts quality of life during treatment.See study design

What are the potential side effects?

Since the intervention involves using a mobile app for monitoring, direct physical side effects are not expected from the Ecologic Momentary Assessment itself. However, participants may experience stress or emotional discomfort while reporting symptoms.

QUADSHOT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 75 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~75 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 75 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient perceptions of mHealth platform

Patient satisfaction via qualitative interview and app based EMAs

Secondary outcome measures

Changes in weekly FACT-HN scores over time

Completion rates of daily questionnaires

Feasibility of intervention

+1 more

QUADSHOT Trial Design

1Treatment groups

Experimental Treatment

Group I: Ecological Momentary Assessments (EMAs)Experimental Treatment1 Intervention

Patients will receive one EMA (Ecologic Momentary Assessment) per day for approximately 75 days, through the provided smart phone application.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

95,908 Total Patients Enrolled

Media Library

Ecological Momentary Assessments (EMAs) Clinical Trial Eligibility Overview. Trial Name: NCT05850663 — N/A

Head and Neck Cancers Research Study Groups: Ecological Momentary Assessments (EMAs)

Head and Neck Cancers Clinical Trial 2023: Ecological Momentary Assessments (EMAs) Highlights & Side Effects. Trial Name: NCT05850663 — N/A

Ecological Momentary Assessments (EMAs) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05850663 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for prospective participants in this clinical trial?

"According to the information available on clinicialtrials.gov, this clinical trial is actively looking for patients with a start date of May 1st 2023 and an update posted on April 28th 2023."

Answered by AI

What tangible effects is this experiment expected to yield?

"This 75-day medical trial seeks to measure patient's reactions towards mHealth platforms. Secondary objectives include measuring completion rates of daily questionnaires, assessing any impediments to care through qualitative interviews and app based EMAs, as well as ascertaining the feasibility of the intervention by tracking those who complete at least 75% of phone-based assessments with accompanying app technology."

Answered by AI

What is the current maximum capacity of enrollees for this research endeavor?

"Confirmed. Details on clinicaltrials.gov suggest that this experiment is actively seeking participants. It was initially uploaded to the website on May 1st 2023 and most recently updated April 28th 2023 with a goal of enrolling 15 patients at one facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

2024. "Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05850663.